Association of statin and/or renin-angiotensin-aldosterone system modulating therapy with mortality in adults with diabetes admitted to hospital with COVID-19: A retrospective multicentre European study

BACKGROUND & AIMS: To assess the impact of pre-admission renin-angiotensin-aldosterone system inhibitor (RAASi) and statin use on mortality following COVID-19 hospitalization in adults with pre-existing diabetes. METHODS: Retrospective cohort study of adults with diabetes admitted to ninety-nine...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Sophie, Ruan, Yue, Wild, Sarah H., Wargny, Matthieu, Hadjadj, Samy, Delasalle, Béatrice, Saignes, Maëva, Ryder, Robert EJ., Field, Benjamin C.T., Narendran, Parth, Zaccardi, Francesco, Wilmot, Emma G., Vlacho, Bogdan, Llauradó, Gemma, Mauricio, Didac, Nagi, Dinesh, Patel, Dipesh, Várnai, Kinga A., Davies, Jim, Gourdy, Pierre, Cariou, Bertrand, Rea, Rustam, Khunti, Kamlesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996468/
https://www.ncbi.nlm.nih.gov/pubmed/35472685
http://dx.doi.org/10.1016/j.dsx.2022.102484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996468/
https://www.ncbi.nlm.nih.gov/pubmed/35472685
http://dx.doi.org/10.1016/j.dsx.2022.102484

Ejemplares similares